724P Anti-PD-1 antibody SHR-1210 combined with apatinib as adjuvant treatment in patients with hepatocellular carcinoma at high risk of recurrence after radical resection: Preliminary results from a multicenter, randomized, controlled phase II trial
Hao-Yun Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Shanmei Du(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhini Zhu(Chinese PLA General Hospital), L. Jiang(Capital Medical University), X. Che(Chinese Academy of Medical Sciences & Peking Union Medical College), H. Qian(Peking University), Jingyi Song(Beijing Hospital), Dan Liu(Capital Medical University), Y. Zhang(Harbin Medical University), Puyue Zhang(First Bethune Hospital of Jilin University), Yangle Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Weimin Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yu‐kai Tang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 2
Abstract
Related Papers
No related papers found
Powered by citation graph analysis